# EFFORT Further Extension Study

> **NCT02826070** · PHASE4 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 130 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Telbivudine
- **DRUG:** Adefovir dipivoxil
- **OTHER:** off-treatment follow-up

## Key facts

- **NCT ID:** NCT02826070
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2016-07-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02826070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02826070, "EFFORT Further Extension Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02826070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*